Minderoo Foundation, established in 2001 and located in Nedlands, Australia, is a nonprofit organization that operates as a venture capital firm and impact investor. The foundation focuses on empowering individuals and communities by fostering inclusion, collaboration, and kindness. It targets investments in various sectors, including healthcare, clean technology, education services, and environmental initiatives. Through its philanthropic efforts, Minderoo Foundation aims to generate positive social and environmental outcomes while addressing pressing global challenges.
Planet Protector Group specializes in the manufacture and distribution of insulated packaging solutions created from 100% natural waste wool. The company aims to eliminate polystyrene from the packaging industry by offering sustainable and eco-friendly alternatives. Their products are designed for use in the food and pharmaceutical sectors, providing reusable, renewable, and thermally insulative options. By utilizing waste materials, Planet Protector Group enables its clients to adopt environmentally responsible practices while maintaining effective packaging performance.
FarmInsect
Series A in 2023
FarmInsect GmbH, founded in 2019 and based in Bergkirchen, Germany, specializes in automated insect breeding systems designed to provide a sustainable and efficient source of animal feed. The company focuses on enabling local farmers to produce insect larvae from organic residues, which can be used as protein feed for livestock such as chickens, pigs, and fish. By offering a solution that replaces imported soy and fishmeal with locally sourced insect protein, FarmInsect aims to enhance the sustainability of animal husbandry while ensuring that farmers have a consistent supply of young larvae each week for their feeding needs.
Sustainable Screens Australia
Seed Round in 2023
Sustainable Screens Australia mission to inspire and enable productions to minimise their environmental impact.
FairSupply
Series A in 2022
FairSupply offers a cloud-based platform that focuses on environmental, social, and corporate governance (ESG) risk management and compliance. The company specializes in providing comprehensive supply chain visibility, allowing corporate and institutional clients to identify and assess ESG risks throughout their supply chains. By leveraging advanced data from global ESG data providers, FairSupply's solution enhances clients' understanding of potential risks, thereby facilitating informed decision-making and promoting responsible business practices.
Proximie
Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.
Her Black Book
Seed Round in 2022
Her Black Book is a curated Shopping & Discovery App, for women who love to shop. The chic platform enables shoppers to browse for their favourite brands, discover new products, great deals, and promos via discounts and Cashback features. HBB provides retailers a premium incentive destination that aligns with their brand's style and values and offers a digital magazine of styling tips and engaging content across fashion, beauty, lifestyle, and business.
Getlabs
Series A in 2022
Getlabs, Inc. is a digital health platform based in Santa Monica, California, that specializes in at-home diagnostics. Founded in 2018, the company facilitates the scheduling of home lab appointments, where mobile phlebotomists visit patients to collect blood samples and other diagnostic tests. These samples are then delivered to laboratories for processing, allowing healthcare organizations to enhance patient care and adherence by providing same-day, nationwide service. Getlabs aims to bridge the gap between virtual and in-person healthcare, thereby improving access to essential diagnostic services. The company has secured $50 million in funding from strategic investors, including major diagnostic laboratories.
Mr. Green Africa
Series B in 2022
Mr. Green Africa Ltd is a Nairobi-based plastic recycling company established in 2014 that addresses waste management challenges in Kenya. The company specializes in the collection, conversion, and sale of post-consumer plastic waste, producing a range of recycled materials including rHDPE and rPP pellets in various colors, as well as rPET products. Mr. Green Africa aims to change perceptions of waste by demonstrating its value and incorporates the concept of shared value into its operations, creating economic benefits while tackling social and environmental issues. By integrating informal waste workers and micro-entrepreneurs into a formal value chain, the company enhances waste collection efficiency and promotes sustainability.
Inrupt
Series A in 2021
Inrupt, Inc. is a company that develops an open-source platform aimed at decentralizing the web through a set of modular specifications. Its primary offering, Solid, allows users and organizations to separate their data from the applications that utilize it, thereby enabling individuals to manage and secure their personal online data stores. This platform facilitates the simultaneous use of data across various applications, empowering users while providing new value creation opportunities for organizations. Inrupt serves a diverse clientele that includes developers, businesses, and end users. Founded in 2013 and headquartered in Boston, Massachusetts, Inrupt is committed to realizing Sir Tim Berners-Lee's vision of a web that benefits everyone by putting individuals in control of their data and fostering an innovative marketplace.
Buildsafe Queensland
Grant in 2021
Buildsafe Queensland offers innovative height safety solutions, and provide a simple service that compliments the construction process.
Ena Respiratory
Venture Round in 2021
Ena Respiratory Pty Ltd is a biotechnology company based in Melbourne, Australia, established in 2020. The company focuses on developing synthetic innate immunomodulators aimed at transforming the treatment and prevention of respiratory infections. Ena Respiratory's novel synthetic Toll-like receptor 2 (TLR2) receptor agonists are designed to activate the innate immune system specifically in the respiratory tract. This innovative approach enables targeted delivery to the airways, helping to prevent the dissemination of viral and bacterial infections to the lungs. By enhancing the immune response, Ena Respiratory aims to protect patients with pre-existing lung conditions from severe complications associated with respiratory infections.
Ena Respiratory
Venture Round in 2021
Ena Respiratory Pty Ltd is a biotechnology company based in Melbourne, Australia, established in 2020. The company focuses on developing synthetic innate immunomodulators aimed at transforming the treatment and prevention of respiratory infections. Ena Respiratory's novel synthetic Toll-like receptor 2 (TLR2) receptor agonists are designed to activate the innate immune system specifically in the respiratory tract. This innovative approach enables targeted delivery to the airways, helping to prevent the dissemination of viral and bacterial infections to the lungs. By enhancing the immune response, Ena Respiratory aims to protect patients with pre-existing lung conditions from severe complications associated with respiratory infections.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.